Evidence

BROWSE BY STUDY TYPE OR CONFERENCE
All
  • All
  • MODEL VALIDATION
  • CLINICAL VALIDATION
  • AACR
  • ASCO
  • ASH
BROWSE BY YEAR
All
  • All
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • Archive
Predicting Non-Responders to Immunotherapy Treatments through Simulation of NGS Information

Blood Journal,

In Silico Modeling of Oncogenic Drivers in Waldenstrom Macroglobulinemia to Assess Additional Therapeutic Targets within the BCR Signaling Pathway Identifies MEK1/2 As a Target: Potential Therapeutic Role of Binimetinib

Blood Journal,

Aurora Kinase Is a Therapeutic Target in Ibrutinib-Resistant Waldenstrom Macroglobulinemia: In silico Target Identification and in vitro Validation

Blood Journal,

Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide

Oncotarget,

In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment

Antimicrobial Agents and Chemotherapy,

Predictive simulation-driven personalization methodology for refractory multiple myeloma

AACR Annual Meeting,

Identification and therapeutic targeting of signaling pathways in Ruxolitinib resistant cells

AACR Annual Meeting,

Effectiveness of Predictive Simulation in Identifying Potential Patient-Specific Therapeutic Targets in Multiple Myeloma-A Pilot Study

AACR Annual Meeting,

STAY INFORMED

Top